NDN and ovarian cancer: To determine whether aberrant epigenetic modifications regulate NDN expression in ovarian cancers, the same 10 ovarian cancer cell lines were treated with a demethylating agent 5-aza-2′-deoxycytidine (DAC) (Figure 7).